Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation

Journal of Hepatology

Volumn 39, Issue 3, 2003, Pages 447-452

  Lykavieris, Panayotis ^a   Van Mil, Saskia ^b   Cresteil, Danièle ^a   Fabre, Monique ^a   Hadchouel, Michelle ^a   Klomp, Leo ^b   Bernard, Olivier ^a   Jacquemin, Emmanuel ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Children; Extrahepatic features; Familial intrahepatic cholestasis type 1; Liver transplantation; Progressive familial intrahepatic cholestasis

Indexed keywords

COLESTYRAMINE; GAMMA GLUTAMYLTRANSFERASE; GENOMIC DNA; STEROID; TACROLIMUS;

ARTICLE; CASE REPORT; CATCH UP GROWTH; CHILD; CHRONIC DIARRHEA; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; ENZYME ACTIVITY; FAMILIAL DISEASE; FATTY LIVER; FIC1 GENE; GENE; GENE DELETION; GENE SEQUENCE; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER TRANSPLANTATION; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT STATURE; TREATMENT OUTCOME;

EID: 0042830239     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00286-1     Document Type: Article

References (33)

1. Clayton RJ, Iber FL, Ruebner BH, McKusick VA. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. J Pediatr 1965;67:1025-1028.
2. Clayton RJ, Iber FL, Ruebner BH, McKusick VA. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969;117:112-124.
3. Linarelli LG, Williams CN, Phillips MJ. Byler's disease: fatal intrahepatic cholestasis. J Pediatr 1972;81:484-492.
4. Jacquemin E, Hadchouel M. Genetic basis of progressive familial intrahepatic cholestasis. J Hepatol 1999;31:377-381.
5. Jacquemin E. Progressive familial intrahepatic cholestasis: genetic basis and treatment. Clin Liver Dis 2000;4:753-763.
6. Bull LN, Carlton VEH, Stricker NL, Baharloo S, De Young JA, Freimer NB, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26:155-164.
7. Bull LN, van Eijk MJT, Pawlikowska L, De Young JA, Juijn JA, Liao M, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-224.
8. Van Mil SWC, Klomp L, Bull L, Houwen RHJ. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liv Dis 2001;21:535-544.
9. Van Ooteghem NAM, Klomp LWJ, Van Berge-Henegouwen GP, Houwen RHJ. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol 2002;36:439-443.
10. Ujhazy P, Ortiz D, Misra S, Arias IM. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 2001;34:768-775.
11. Eppens EF, van Mil SW, de Vree JM, Mok KS, Juijn JA, Elferink RPJ, et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol 2001;35:436-443.
12. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20:233-238.
13. Thompson R, Strautnieks S. BSEP: function and role in progressive familial intrahepatic cholestasis. Semin Liv Dis 2001;21:545-550.
14. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur J Pediatr 1994;153:424-428.
15. Jansen PLM, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJEJ. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999;117:1370-1379.
16. Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). J Pediatr Surg 1995;30:1635-1641.
17. Ismail H, Kalicinski P, Markiewicz M, Jankowska I, Pawlowska J, Kluge P, et al. Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion. Pediatr Transplant 1999;3:219-224.
18. Chen HL, Chang PS, Hsu HC, Ni YH, Hsu HY, Lee JH, et al. FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels. J Pediatr 2002;140:119-124.
19. Knisely AS. Progressive familial intrahepatic cholestasis: a personal perspective. Pediatr Dev Pathol 2000;3:113-125.
20. Klomp LWJ, Bull LN, Knisely AS, Van der Doelen MA, Juijn JA, Berger R, et al. A missense mutation in FIC1 is associated with Greenland familial cholestasis. Hepatology 2000;32:1337-1341.
21. Soubrane O, Gauthier F, Devictor D, Bernard O, Valayer J, Houssin D, et al. Othotopic liver transplantation for Byler disease. Transplantation 1990;50:804-806.
22. Winklhofer-Roob BM, Shmerling DH, Soler R, Briner J. Progressive idiopathic cholestasis presenting with profuse watery diarrhoea and recurrent infections (Byler's disease). Acta Paediatr Scand 1992;81:637-640.
23. Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994;18:128-133.
24. Bull LN, Freimer N, Czubkowski P, Pawlowska J, Jankowska I, Lacaille F, et al. Clinical and biochemical features of FIC1 (ATP8B1) and BSEP (ABCB11) disease. Hepatology 2002;36:310A.
25. Knisely AS, Boyle JT, Naylor EW, Klinger K, Freimer NB, Kocoshis S. Pancreatic dysfunction in Byler disease. J Pediatr Gastroenterol Nutr 1995;21:328.
26. Oshima T, Ikeda K, Takasaka T. Sensorineural hearing loss associated with Byler disease. Tohoku J Exp Med 1999;187:83-88.
27. Egawa H, Yorifuji T, Sumazaki R, Kimura A, Hasegawa M, Tanaka K. Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resine. Liver Transplant 2002;8:714-716.
28. Tygstrup N, Steig BA, Juijn JA, Bull LN, Houwen RHJ. Recurrent familial intrahepatic cholestasis in the Faeroe islands. Phenotypic heterogeneity but genetic homogeneity. Hepatology 1999;29:506-508.
29. Lykavieris P, Cresteil D, Fabre M, Hadchouel M, Bernard O, Jacquemin E. Catch-up growth failure, refractory diarrhea, and appearance of liver steatosis in PFIC1 patients after liver transplantation or biliary diversion. J Pediatr Gastroenterol Nutr 2002;34:434A.
30. Pawlikowska L, Ottenhoff R, Looije N, Eppens EF, Knisely AS, Bull LN, et al. FIC1 mutant mice have a defect in the regulation of intestinal bile salt absorption. Hepatology 2001;34:240A.
31. Oude Elferink RPJ, Pawlikowska L, Looije N, Ottenhoff R, Eppens E, Paulusma C, et al. Defective regulation of ASBT activity in FIC1 mutant mice. Hepatology 2002;36:334A.
32. Bhagat G, Lobritto SJ, Lefkowitch JH, Bourke B, McDermott M, Portmann BC, et al. Allograft steatosis is a feature of progressive familial intrahepatic cholestasis type 1 (FIC1 disease), treated by orthotopic liver transplantation (OLTX). Hepatology 2001;34:209A.
33. Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997;25:519-523.